BMC Health Services Research

This article estimates the cost-effectiveness of the antiviral remdesivir, as recommended in the 2021 COVID treatment guidelines for the United Arab Emirates, compared to favipiravir (FAVI), which was also recommended for the treatment of hospitalized COVID patients.

Journal Article